Jason K Baxter1, Louis Weinstein. 1. Department of Obstetrics and Gynecology, Fellow, Division of Maternal-Fetal Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Jason.Baxter@jefferson.edu
Abstract
UNLABELLED: Preeclampsia/eclampsia has been recognized for centuries and continues to plague both the patient and the obstetrician. A severe variant, the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP), has been recognized for 50 years. Although much new data has been elucidated about the condition, only several observations have withstood the test of time. These are the uniqueness of the disease to humans, the progressive nature of the disease, and the fact that delivery is the sole therapy. TARGET AUDIENCE: Obstetricians & Gynecologists, Family Physicians. LEARNING OBJECTIVES: After completion of this article, the reader should be able to outline the history of HELLP syndrome and describe the pathophysiology of HELLP syndrome, to summarize the clinical presentation and differential diagnosis of HELLP syndrome, and to list the various management options.
UNLABELLED: Preeclampsia/eclampsia has been recognized for centuries and continues to plague both the patient and the obstetrician. A severe variant, the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP), has been recognized for 50 years. Although much new data has been elucidated about the condition, only several observations have withstood the test of time. These are the uniqueness of the disease to humans, the progressive nature of the disease, and the fact that delivery is the sole therapy. TARGET AUDIENCE: Obstetricians & Gynecologists, Family Physicians. LEARNING OBJECTIVES: After completion of this article, the reader should be able to outline the history of HELLP syndrome and describe the pathophysiology of HELLP syndrome, to summarize the clinical presentation and differential diagnosis of HELLP syndrome, and to list the various management options.
Authors: Cees B M Oudejans; Marie van Dijk; Marjet Oosterkamp; Augusta Lachmeijer; Marinus A Blankenstein Journal: Hum Genet Date: 2006-09-26 Impact factor: 4.132
Authors: Marie van Dijk; Hari K Thulluru; Joyce Mulders; Omar J Michel; Ankie Poutsma; Sandra Windhorst; Gunilla Kleiverda; Daoud Sie; Augusta M A Lachmeijer; Cees B M Oudejans Journal: J Clin Invest Date: 2012-10-24 Impact factor: 14.808
Authors: T Várkonyi; B Nagy; T Füle; A L Tarca; K Karászi; J Schönléber; P Hupuczi; N Mihalik; I Kovalszky; J Rigó; H Meiri; Z Papp; R Romero; N G Than Journal: Placenta Date: 2010-06-11 Impact factor: 3.481
Authors: Arrigo Fruscalzo; R Schmitz; W Klockenbusch; G Köhler; A P Londero; M Siwetz; B Huppertz Journal: Histochem Cell Biol Date: 2012-07-31 Impact factor: 4.304